Nabil Saba

106PUBLICATIONS
323CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsiesMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (106)

|Sep 11, 2026
A systematic review of international/national guidelines for the management of nasopharyngeal carcinoma: Convergence and divergence of recommendations.

|Sep 07, 2026
Blueberry Extract Has Anti-Proliferative Activity in Preclinical Models of Head and Neck Cancer.

|Aug 31, 2026
The Molecular and Immunological Landscape in Nasopharyngeal Carcinoma (NPC) Differs by Somatostatin Receptor 2 (SSTR2) Expression.

|Aug 19, 2026
Danvatirsen plus pembrolizumab versus pembrolizumab for recurrent and/or metastatic head and neck squamous cell carcinoma (PEMDA-HN): a randomized, phase 2 trial.

|Jul 21, 2026
Tobacco Use and Cessation Patterns Among Cancer Survivors: Results From Nine ECOG-ACRIN Cancer Research Group Trials.

|Jul 10, 2026
Immunotherapeutic Approaches to Head and Neck Squamous Cell Carcinoma: Current Clinical Practice and Future Directions.

Pageof 18

Frequent Collaborators

23 joint publications

Alfio Ferlito

15 joint publications

Yong Teng

14 joint publications

Juan Pablo Rodrigo

14 joint publications

Antti Mäkitie